Company Search

Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Share Prices
Oxford Biomedica Share Price
Oxford Biomedica Share News

Oxford Biomedica (OXB) Share News

6 7 8 9 10 11 12 13 1415

Oxford Biomedica Regains Rights For RetinoStat After Sanofi Opts Out

29th Apr 2014 09:48

LONDON (Alliance News) - Oxford Biomedica PLC said Tuesday that it will regain the worldwide rights to its treatment for wet age-related macular generation treatment RetinoStat from Sanofi SA, after Sanofi decided not to continue developing the treatment. Sanofi has opted not to continue de Read More

Oxford Biomedica Pretax Loss Widens As Sanofi Collaboration Winds Down

10th Apr 2014 11:13

LONDON (Alliance News) - Oxford Biomedica PLC Thursday posted a widened pretax loss for 2013, as revenue wound down from its long-term collaboration with Sanofi S.A, although the company expressed confidence for 2014 as it looks to shift towards a more self-sustaining model. Oxford Biomedic Read More

UK Earnings, Trading Statements Calendar - Week Ahead

10th Apr 2014 05:09

UK Earnings, Trading Statements Calendar - Week Ahead

9th Apr 2014 15:25

UK Earnings, Trading Statements Calendar - Week Ahead

9th Apr 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

8th Apr 2014 15:14

UK Earnings, Trading Statements Calendar - Week Ahead

8th Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

7th Apr 2014 14:50

Oxford Biomedica Finishes Recruitment For Phase I RetinoStat Trial

7th Apr 2014 09:40

LONDON (Alliance News) - Oxford Biomedica PLC said Monday it had completed patient recruitment for its Phase I trial of neovascular wet age-related macular degeneration treatment RetinoStat. The condition is age related, and causes blindness and visual impairment. The company said tha Read More

FTSE 100 Latest

Value8,774.65

Change-17.15